R-DHAP vs POLA-R-DHAP Followed by Autologous Transplant as First Salvage Treatment in Patient With Relapsed or Refractory Diffuse Large B Cell Lymphoma
Clinical trial NCT05966233 · WITHDRAWN
Trial details
- NCT number
- NCT05966233
- Sponsor
- Fondazione Italiana Linfomi - ETS
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-01
- Primary completion
- 2029-01-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.